|Articles|April 12, 2016
OmniComm Penetrates Growing Israeli Life Sciences Market
OmniComm has announced the signing of an agreement with Medistat Ltd.
Advertisement
OmniComm has announced the signing of an agreement with Medistat Ltd., headquartered in Tel Aviv, Israel; to address the clinical trial needs of the growing Israeli life sciences sector. Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
ACT Brief: AstraZeneca Expands Immunotherapy Reach as Thermo Fisher’s $8.8B Deal Signals New Phase for Digital Trials
2
Engineered Bispecific Antibodies: Regulatory, Ethical, and Best Practice Guidelines
3
MATTERHORN Trial Findings Signal Paradigm Shift in Early Gastric Cancer Care
4
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
